Department of Orthopedics, Peking University Third Hospital, Beijing, 100191, China.
Engineering Research Center of Bone and Joint Precision Medicine, Ministry of Education, Beijing, 100191, China.
Tissue Eng Regen Med. 2023 Oct;20(6):829-837. doi: 10.1007/s13770-023-00569-2. Epub 2023 Aug 10.
Due to its high water content and biomimetic properties simulating extracellular matrix (ECM), hydrogels have been used as preferred cell culture and delivery systems. Similarly, cell-loaded hydrogels can be easily injected into target areas in a minimally invasive manner, minimizing surgical trauma, adapting to irregular shaped defects, and benefiting patients. In this study, we systematically reviewed multiple studies on hydrogel-based bone defect research and briefly summarized the progress of injectable and cell-loaded hydrogels in bone defect repair.
A systematic search was conducted in the PubMed and Web of Science databases using selected search terms.
Initially, 185 articles were retrieved from the databases. After full-text screening based on inclusion and exclusion criteria, 26 articles were included in this systematic review. Data collected from each study included culture model, seed cell type and origin, cell concentration, scaffold material, scaffold shape, experimental animal and site, bioactive agents, and binding method. This injectable and cell-loaded hydrogel shows certain feasibility in bone tissue engineering applications.
Injectable and cell-loaded hydrogels have been widely applied in bone tissue engineering research. The future direction of bone tissue engineering for bone defect treatment involves the use of new hydrogel materials and biochemical stimulation.
由于其高含水量和仿生特性模拟细胞外基质(ECM),水凝胶已被用作首选的细胞培养和输送系统。同样,负载细胞的水凝胶可以通过微创的方式轻松注入目标区域,最大限度地减少手术创伤,适应不规则形状的缺陷,并使患者受益。在这项研究中,我们系统地回顾了多项基于水凝胶的骨缺损研究,并简要总结了可注射和负载细胞的水凝胶在骨缺损修复中的进展。
使用选定的搜索词在 PubMed 和 Web of Science 数据库中进行了系统搜索。
最初从数据库中检索到 185 篇文章。根据纳入和排除标准进行全文筛选后,本系统评价纳入 26 篇文章。从每项研究中收集的数据包括培养模型、种子细胞类型和来源、细胞浓度、支架材料、支架形状、实验动物和部位、生物活性物质和结合方法。这种可注射和负载细胞的水凝胶在骨组织工程应用中显示出一定的可行性。
可注射和负载细胞的水凝胶已广泛应用于骨组织工程研究。未来骨组织工程治疗骨缺损的方向涉及使用新的水凝胶材料和生化刺激。